If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPalace Capital Regulatory News (PCA)

Share Price Information for Palace Capital (PCA)

Share Price is delayed by 15 minutes
Get Live Data
173.00    -0.50 (-0.29%)
Bid:
173.00
Ask:
177.50
Spread: 4.50 (2.601%)
Market Cap: £33.78m
PCA Live PriceLast checked at - London Stock Exchange

Intraday Palace Capital Share Chart

New £40 million banking facility

26 Jan 2018 07:00

RNS Number : 9820C
Palace Capital PLC
26 January 2018
 

Prior to publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement, this information is now considered to be in the public domain.

 

Palace Capital PLC

("Palace Capital" or the "Company")

 

PALACE CAPITAL SIGNS £40M FACILITY WITH BARCLAYS

 

Palace Capital, the property investment company that focuses on commercial property outside London, is pleased to announce that it has entered into a new 5-year £40 million bank facility with Barclays Bank.

 

At the time of the acquisition of RT Warren (Investments) Limited ("RT Warren"), the Company stated that it had assumed an existing loan from Barclays Bank of £14.5 million. This bank facility was due to expire on 31 January 2018.

 

In discussions with Barclays Bank, the Company has taken the opportunity of not only agreeing a new, increased 5-year facility secured on the RT Warren commercial properties, but also to repay the Company's £12.7 million facility with Nationwide, which was due to expire in November 2020.

 

The new facility with Barclays Bank carries a margin of 1.95% over LIBOR, which further reduces the Company's average cost of debt to below 3% and extends the average debt maturity to 4.7 years.

 

As at 24 January 2018, the company has net debt of £84.2 million, representing a loan to value (LTV) net of cash of 31%. The Company now has combined facilities of £115.4 million, providing greater firepower for further acquisitions.

 

Neil Sinclair, Chief Executive of Palace Capital, commented: "We are delighted to have entered into this new facility on very competitive terms as we continue to demonstrate one of the lowest overall costs of debt in our sector. We are strong advocates of relationship banking and have been well supported by our key lenders through this latest growth phase. The new facility will enable us to pursue more opportunities to grow both income and capital value, underpinning our commitment to enhance cash returns to our shareholders."

 

Date: 26 January 2018

 

For further information, contact:

 

Palace Capital plc

Neil Sinclair, Chief Executive

Stephen Silvester, Finance Director

Tel. +44 (0)20 3301 8331

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

Nick Naylor / James Reeve / Asha Chotai

Tel. +44 (0)20 3328 5656

 

Arden Partners plc (Joint Broker)

Chris Hardie / Ciaran Walsh

Tel. +44 (0)207 614 5917

 

Capital Access Group (Financial PR)

Scott Fulton

Tel. +44 (0)20 3763 3400

 

About Palace Capital plc (www.palacecapitalplc.com):

 

Palace Capital is a UK property investment company admitted to trading on the AIM Market of the London Stock Exchange (LSE: PCA). The Company has a diversified portfolio and looks for opportunities where it can enhance the long-term income and capital value through asset management and strategic capital development in locations outside London. In its last reported financial year, Palace Capital produced a 20.0% increase in adjusted profit before tax, a 7.0% uplift in EPRA NAV per share and a 16.0% increase in dividends.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBAMRTMBJTBPP
Date   Source Headline
17th Apr 20257:00 amRNSHolding(s) in Company
11th Apr 20251:30 pmRNSDISPOSALS, DEBT AND CASH UPDATE
11th Mar 20257:00 amRNSDividend Declaration
10th Dec 20241:12 pmRNSHolding(s) in Company
15th Nov 202412:59 pmRNSHolding(s) in Company
14th Nov 20247:00 amRNSInterim Results
12th Nov 202412:00 pmRNSNotice of Results
9th Oct 202412:16 pmRNSHolding(s) in Company
24th Sep 202412:00 pmRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDividend Declaration
2nd Aug 20247:00 amRNSDirector/PDMR Shareholding
24th Jul 202411:03 amRNSResult of AGM
24th Jul 202410:53 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDISPOSALS AND CASH UPDATE
22nd Jul 20248:55 amRNSHolding(s) in Company
18th Jul 20247:00 amRNSDirector/PDMR Shareholding
17th Jul 20242:30 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSTransaction in Own Shares
11th Jul 20247:00 amRNSResult of Tender Offer
9th Jul 202410:45 amRNSResult of General Meeting
19th Jun 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
13th Jun 20247:00 amRNSTender Offer
6th Jun 20247:00 amRNSPreliminary Results for year ended 31 March 2024
4th Jun 20247:00 amRNSNotice of Results
29th Apr 20241:15 pmRNSBoulton House disposal
18th Apr 20247:00 amRNSDISPOSALS AND DEBT UPDATE
28th Mar 202412:45 pmRNSTotal Voting Rights
12th Mar 20247:00 amRNSDividend Declaration
8th Feb 20243:49 pmRNSHolding(s) in Company - Amendment
8th Feb 20243:30 pmRNSHolding(s) in Company
8th Feb 20243:29 pmRNSHolding(s) in Company
7th Feb 20247:00 amRNSDISPOSALS AND DEBT UPDATE
4th Dec 20234:00 pmRNSResult of General Meeting
15th Nov 20233:15 pmRNSHolding(s) in Company
15th Nov 20237:02 amRNSNotice of General Meeting
15th Nov 20237:01 amRNSDirectorate Change
15th Nov 20237:00 amRNSInterim Results
17th Oct 20234:00 pmRNSDirector/PDMR Shareholding
14th Sep 20237:00 amRNSDividend Declaration
6th Sep 20237:00 amRNSTransaction in Own Shares
4th Sep 20231:40 pmRNSDirector Declaration
29th Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
21st Aug 20237:00 amRNSDirector Dealing
15th Aug 202310:07 amRNSNotification of Major Holdings
15th Aug 20239:56 amRNSNotification of Major Holdings
14th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20237:00 amRNSTransaction in Own Shares
8th Aug 20237:00 amRNSShare Buyback and Total Voting Rights
2nd Aug 20237:00 amRNSSale of Maidenhead office property for £9.6m

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.